Connect your AI

NuSkin Enterprises NUS Divestiture of businesses, net of cash transferred

Divestiture of businesses, net of cash transferred at other companies

LKQLKQ

$99.25M+3,709%

BioCryst PharmaceuticalsBCRX

-$1.55M—

Community Health SystemsCYH

$1.11B+96.8%

The Baldwin Insurance Group, Inc.BWIN

$0-100%

Republic ServicesRSG

$1M-66.7%

ConstelliumCSTM

-$250K—

Other financials

Income statement

Revenue$320.6M-12.0%

Gross profit$214.5M-13.2%

Operating income$4.0M+141%

Net income$1.8M-98.3%

EPS (diluted)$0.04-98.1%

Balance sheet

Cash & equivalents$198.7M-2.5%

Total debt$303.6M-8.2%

Total equity$794.1M+5.3%

Total assets$1.4B-1.1%

Cash flow

Operating cash flow-$3.9M-1,107%

CapEx$13.7M+1.0%

Free cash flow-$17.6M-33.6%

Valuation

Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's divestiture of businesses, net of cash transferred.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is NuSkin Enterprises's divestiture of businesses, net of cash transferred?: NuSkin Enterprises (NUS) reported divestiture of businesses, net of cash transferred of $0 in Q1 2026.
How has NuSkin Enterprises's divestiture of businesses, net of cash transferred changed year-over-year?: NuSkin Enterprises's divestiture of businesses, net of cash transferred decreased by 100.0% year-over-year, from $193.73M to $0.